leisure time -WSS

leisure time

author：entertainment 2025-08-28 08:40:16 - browse：98756

Each COVID-19 vaccine vial from various companies is placed on individual rectangular backgrounds. Pfizer-BioNTech is positioned in the middle on a purple block adorned with two glitter star stickers, Moderna is on the top right on a red block, Janssen is on the bottom right on a blue block, and AstraZeneca is on the left on a red block. — Illustration: Christine Kao/STAT; Photos: Getty

It’s been four years since Covid-19 emerged, igniting a pandemic that killed millions of people and brought the world to its knees. A key factor in taming the pandemic was the creation of effective vaccines, which have saved millions of lives.

You’d think developing a successful vaccine would be an unmitigated win, from a financial perspective. And, indeed, for Pfizer and its partner BioNTech, as well as for Moderna — whose vaccines were the most widely used in the United States and much of the world — the revenues generated were absolutely staggering. But investors have shrugged at those sales as gains that will not be repeated.

Total sales of the Pfizer/BioNTech vaccine surpassed $80 billion, and more than 400 million doses of the shot and subsequent boosters have been administered in the U.S. alone. But the company’s stock price fell 32% over the past five years. Meanwhile, AstraZeneca, which told STAT it has not booked sales from its vaccine since last April and does not expect future sales, has seen its share price rise 64%. Merck, which saw its vaccine efforts fail twice, is up 56%.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： In age of alternative facts, a scholarly course on calling out crap
Next article： Pharma needs to include young adults in clinical research

focus

WSS

US Marines prepare to be put on commercial ships to deter Iranian harassment in Strait of Hormuz

Readout LOUD podcast: live from JPM 2024

Pharma needs to include young adults in clinical research

Fauci’s Covid grilling leads GOP to weigh foreign research rules

Slain Parkland victim's father speaks out following reenactment

Climate activists disrupt London Pride march to protest corporate sponsorship

focus

leisure time

leisure time

Continuity nursing helped my family in our darkest PICU moments

Doudna institute plans to 'cure hundreds of diseases' with CRISPR

Virginia high school admissions case could be legal follow

Taylor Swift shares sweet moment with Kobe Bryant's daughter Bianka at Eras Tour concert

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Medical schools are missing the mark on artificial intelligence

Dobbs anniversary: the lost opportunity of abortion as health care

Generative AI mines health records to identify patients’ social needs

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Three issues to watch in global health in 2024

focus

DeSantis can now import cheaper drugs. But will Biden get credit?

What to know about 'Guardians of the Galaxy Vol. 3' as it hits Disney+

JPM 2024: Verve Therapeutics looks to mainstream genome editing

Teen charged with murder as hate crime in killing of NYC dancer O'Shae Sibley: Sources

Rock icon Freddie Mercury pre

Readout LOUD podcast: live from JPM 2024

explore

focus

hotspot

leisure time